Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Moleculin Biotech, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +2 vs. Q3 2023
- Shares held
- 5.18M
- +3.03M (+140.8%) vs. Q3 2023
- Total value
- $4.44M
- +$3.51M (+379.8%) vs. Q3 2023
- New holders
- 7
- 4 more added
- Sold out
- 5
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $518.5K |
| Q1 2026 | 20 | $347.9K |
| Q4 2025 | 17 | $315.2K |
| Q3 2025 | 25 | $412.7K |
| Q2 2025 | 22 | $117.9K |
| Q1 2025 | 23 | $1.44M |
| Q4 2024 | 21 | $790.0K |
| Q3 2024 | 19 | $1.31M |
| Q2 2024 | 16 | $1.10M |
| Q1 2024 | 19 | $1.53M |
| Q4 2023 | 24 | $4.44M |
| Q3 2023 | 22 | $925.1K |
| Q2 2023 | 22 | $1.33M |
| Q1 2023 | 23 | $2.91M |
| Q4 2022 | 25 | $3.17M |
| Q3 2022 | 27 | $3.16M |
| Q2 2022 | 26 | $4.32M |
| Q1 2022 | 23 | $5.26M |
| Q4 2021 | 26 | $5.61M |
| Q3 2021 | 24 | $8.57M |
| Q2 2021 | 32 | $10.9M |
| Q1 2021 | 29 | $8.74M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Moleculin Biotech, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 3,207,417 | $2.75M | 0.07% | +3,207,417 | New |
| Vanguard Group Inc | 1,080,122 | $927.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 246,670 | $211.8K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 188,924 | $162.2K | 0.00% | −7,374−3.8% | Reduced |
| Renaissance Technologies LLC | 129,600 | $111.0K | 0.00% | +9,400+7.8% | Added |
| State Street Corp | 71,397 | $61.3K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 64,652 | $55.5K | 0.00% | +64,652 | New |
| Northern Trust Corp | 53,596 | $46.0K | 0.00% | 00.0% | Unchanged |
| Atticus Wealth Management, LLC | 50,001 | $42.9K | 0.02% | +50,001 | New |
| Royal Bank of Canada | 20,148 | $17.0K | 0.00% | +19,839+6,420.4% | Added |
| Schmidt P J Investment Management Inc | 29,000 | $14.1K | 0.00% | 00.0% | Unchanged |
| Jmac Enterprises LLC | 13,132 | $11.3K | 0.00% | 00.0% | Unchanged |
| Sigma Planning Corp | 12,000 | $10.3K | 0.00% | −5,000−29.4% | Reduced |
| Tower Research Capital LLC (TRC) | 7,201 | $6.18K | 0.00% | −7,104−49.7% | Reduced |
| Morgan Stanley | 6,334 | $5.44K | 0.00% | 00.0% | Unchanged |
| Sandy Spring Bank | 1,333 | $1.15K | 0.00% | +1,333 | New |
| Advisor Group Holdings, Inc. | 968 | $831 | 0.00% | 00.0% | Unchanged |
| CVA Family Office, LLC | 500 | $429 | 0.00% | +500 | New |
| North Star Investment Management Corp. | 250 | $215 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 229 | $197 | 0.00% | −488−68.1% | Reduced |
| Bank of America Corp | 138 | $118 | 0.00% | +38+38.0% | Added |
| JPMorgan Chase & Co | 52 | $45 | 0.00% | +16+44.4% | Added |
| GWM Advisors LLC | 2 | $2 | 0.00% | +2 | New |
| Hazlett, Burt & Watson, Inc. | 67 | $0 | 0.00% | +67 | New |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −271,230−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −30,493−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |